ClearPoint Neuro, Inc. (CLPT) Net margin 2017–2025
ClearPoint Neuro, Inc. (CLPT) net profit margin by fiscal year — reported net income divided by reported revenue.
-69.1%FY2025 · since FY2017: -97.1% → -69.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -69.1% | -8.8 pp |
| FY2024 | -60.3% | +32.0 pp |
| FY2023 | -92.2% | -12.2 pp |
| FY2022 | -80.0% | +8.4 pp |
| FY2021 | -88.4% | -35.5 pp |
| FY2020 | -52.9% | -3.5 pp |
| FY2019 | -49.4% | +34.4 pp |
| FY2018 | -83.8% | +13.3 pp |
| FY2017 | -97.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating marginCLPT Operating cash flowCLPT Free cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →